May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Retinoblastoma: A Pediatric Ocular Tumor of Possible Stem Cell Origin
Author Affiliations & Notes
  • P. Chevez-Barrios
    Pathology, Methodist Hospital/The Methodist Research Institute, Houston, Texas
    Ophthalmology, Pediatrics,
    Baylor College of Medicine, Houston, Texas
  • L. Wadhwa
    Baylor College of Medicine, Houston, Texas
  • L. Perlaky
    Ophthalmology, Pediatrics,
    Baylor College of Medicine, Houston, Texas
    Texas Children's Hospital, Houston, Texas
  • R. Penland
    Pathology, Methodist Hospital/The Methodist Research Institute, Houston, Texas
  • M. Y. Hurwitz
    Baylor College of Medicine, Houston, Texas
    Texas Children's Hospital, Houston, Texas
  • P. A. Overbeek
    Molecular and Cell Biology,
    Baylor College of Medicine, Houston, Texas
  • R. L. Hurwitz
    Ophthalmology, Pediatrics,
    Baylor College of Medicine, Houston, Texas
    Texas Children's Hospital, Houston, Texas
  • Footnotes
    Commercial Relationships  P. Chevez-Barrios, None; L. Wadhwa, None; L. Perlaky, None; R. Penland, None; M.Y. Hurwitz, None; P.A. Overbeek, None; R.L. Hurwitz, None.
  • Footnotes
    Support  The National Institutes of Health (CA97762),The Clayton Foundation for Research; The Retina Research Foundation;The Knights Templar Eye Research Foundation
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 2011. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      P. Chevez-Barrios, L. Wadhwa, L. Perlaky, R. Penland, M. Y. Hurwitz, P. A. Overbeek, R. L. Hurwitz; Retinoblastoma: A Pediatric Ocular Tumor of Possible Stem Cell Origin. Invest. Ophthalmol. Vis. Sci. 2008;49(13):2011.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Retinoblastoma tumors exhibit heterogeneous morphology and express proteins from different retinal phenotypes. We examined the growth properties of tumors in a transgenic murine model of retinoblastoma and compared our results to human retinoblastoma.

Methods: : Primary human and transgenic (pax6-SV40/T antigen) mouse retinoblastoma tumors were studied in vitro and in vivo for their growth characteristics, morphology and immunophenotype using neural stem cell (NSTC) (CD133, Nestin, Sox2), neuronal differentiation (synaptophysin, NSE), and glial differentiation (GFAP) markers and for T-antigen (murine) or Rb (human) expression.

Results: : Murine retinal tumors develop by embryonic day 12.5 and the majority of these cells express T-antigen. Murine and human tumor cultures produce neurospheres when grown in serum-free "stem cell" media and these cells express both NSTC and differentiation markers in a pattern similar to the primary tumors. Cells grown in serum-containing medium predominately express NSTC markers as do metastases observed in the murine model. Tumor cells grown in vitro can be transplanted into mice where they form tumors that are similar to the original primary tumors. Approximately 10% of cloned cells from neurospheres are capable of proliferating in vitro. The percentage of tumor cells that express T-antigen decreases with the age of the mouse. NSTC markers labeled a small cell population in mouse and human primary tumors. Cells that express T-antigen also express NSTC markers. Many of the cells that did not express T-antigen express Nestin and Sox-2, which are also expressed in the mature human and murine retina. The majority of tumor cells express differentiation markers. Human tumors caused by mutations that do not allow expression of Rb protein do still contain a small population of cells that coexpress Rb and Sox2.

Conclusions: : Retinoblastoma tumors have characteristics consistent with the hypothesis that they develop from a progenitor cell that gives rise to cells with predominant neuronal differentiation. There also appears to be a population of normal cells that form part of the primary ocular but not metastatic tumors.

Keywords: retinoblastoma • differentiation • oncology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×